Author/Authors :
Maleki، Ali نويسنده Assistant Professor, Department of Cardiology, Lorestan University of Medical Sciences, Khorramabad, Iran , , Shariari، Arman نويسنده General Practitioner, Lorestan University of Medical Sciences, Khorramabad, Iran , , Sadeghi، Masoumeh نويسنده , , Rashidi، Negin نويسنده Internist, Imam Khomeini Hospital, Lorestan University of Medical Sciences, Borujerd, Iran , , Alyari، Farshid نويسنده Pathologist, Imam Khomeini Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran , , Forughi، Saeid نويسنده MSc, School of Nursing, Lorestan University of Medical Sciences, Khorramabad, Iran , , Nabatchi، Behjat نويسنده BSc in Nursing, Imam Khomeini Hospital of Lorestan University of Medical Sciences, Lorestan, Iran. , , Ghanavati، Reza نويسنده Cardiologist, Borujerd Hospitals, Borujerd University of Medical Sciences, Borujerd, Iran ,
Abstract :
BACKGROUND: Fibrinolytic therapy is the standard therapeutic method for patients with
acute myocardial infarction (AMI). This study endeavored to assess the delay in arrival to the
emergency department and door to needle time for thrombolytic therapy.
METHODS: This study was conducted on 80 patients with AMI whom referred to our clinic
from January 2009 to January 2010. We measured time of arrival, needle time and door to
needle time for all patients. Moreover, the relations of these times to some variables such as age,
gender and the referred shift of emergency department personnel were calculated.
RESULTS: A total of 80 patients, 62 (77.5%) male and 18 (22.5%) female were evaluated for
thrombolytic therapy. The arrival time of overnight shifts was 14.59 ± 1.23 minutes shorter than
other shifts. The median door to needle time was 46.56 minutes and the mean time of the onset
of chest pain to arrival at the emergency department was 19.44 minutes. Seventy-two patients
(90%) received fibrinolytic therapy within the first 30 minutes of arrival. The needle time was
significantly longer in the night shift (P < 0.05) (between 8 to 14 minutes), while the time of
receiving Streptokinase therapy in the other shifts was not meaningfully different. Finally there
was a statistically significant difference between the referred shifts and needle time (P < 0.05).
CONCLUSION: Despite our good results for door to needle time, to improve and attain the gold
standard’s limits in administering fibrinolytic therapy, improvement of policies like training the
personnel to shorten this time is recommend.
